Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Role of disease risk scores in comparative effectiveness research with emerging therapies.

Glynn RJ, Gagne JJ, Schneeweiss S.

Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:138-47. doi: 10.1002/pds.3231.

2.

Statins for acute coronary syndrome.

Vale N, Nordmann AJ, Schwartz GG, de Lemos J, Colivicchi F, den Hartog F, Ostadal P, Macin SM, Liem AH, Mills EJ, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2014 Sep 1;(9):CD006870. doi: 10.1002/14651858.CD006870.pub3. Review.

PMID:
25178118
3.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2. Review.

PMID:
24880031
4.

Indications for propensity scores and review of their use in pharmacoepidemiology.

Glynn RJ, Schneeweiss S, Stürmer T.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):253-9. Review.

5.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

6.

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.

Arca M, Gaspardone A.

Drugs. 2007;67 Suppl 1:29-42. Review.

PMID:
17910519
7.

Statins for acute coronary syndrome.

Vale N, Nordmann AJ, Schwartz GG, de Lemos J, Colivicchi F, den Hartog F, Ostadal P, Macin SM, Liem AH, Mills E, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006870. doi: 10.1002/14651858.CD006870.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;9:CD006870.

PMID:
21678362
8.

Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.

Kang S, Liu Y, Liu XB.

Clin Ther. 2013 Aug;35(8):1125-36. doi: 10.1016/j.clinthera.2013.06.006. Epub 2013 Aug 7. Review.

PMID:
23932462
9.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD005019. doi: 10.1002/14651858.CD005019.pub4. Review.

PMID:
24470059
10.

Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.

Bangalore S, Fayyad R, Hovingh GK, Laskey R, Vogt L, DeMicco DA, Waters DD; Treating to New Targets Steering Committee and Investigators.

Am J Cardiol. 2014 Jun 15;113(12):2018-20. doi: 10.1016/j.amjcard.2014.03.046. Epub 2014 Apr 3. Review.

PMID:
24793673
11.

Preoperative statin therapy for patients undergoing cardiac surgery.

Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ.

Cochrane Database Syst Rev. 2015 Aug 13;(8):CD008493. doi: 10.1002/14651858.CD008493.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD008493.

PMID:
26270008
12.

Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.

Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P.

Cochrane Database Syst Rev. 2013 Jul 3;(7):CD009971. doi: 10.1002/14651858.CD009971.pub2. Review.

PMID:
23824754
13.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD004289. doi: 10.1002/14651858.CD004289.pub5. Review.

PMID:
24022428
14.

High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.

Benjo AM, El-Hayek GE, Messerli F, DiNicolantonio JJ, Hong MK, Aziz EF, Herzog E, Tamis-Holland JE.

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):53-60. doi: 10.1002/ccd.25302. Epub 2013 Dec 21. Review.

PMID:
24272891
15.

Epidemiologic and statistical methods for comparative effectiveness research.

Hlatky MA, Winkelmayer WC, Setoguchi S.

Heart Fail Clin. 2013 Jan;9(1):29-36. doi: 10.1016/j.hfc.2012.09.007. Epub 2012 Oct 11. Review.

16.

Instrumental variable methods in comparative safety and effectiveness research.

Brookhart MA, Rassen JA, Schneeweiss S.

Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):537-54. doi: 10.1002/pds.1908. Review.

Supplemental Content

Support Center